VYTRUS BIOTECH EO -01 Cash Flow Reinvestment Rate
VYTRUS BIOTECH EO -01 cash flow reinvestment rate. VYTRUS BIOTECH EO -01 (V5P) has a Cash Flow Reinvestment Rate of 0.71x as of December 2025, reinvesting €2.76 Million (capex €2.68 Million plus investments €-80.53K) from operating cash flow of €3.90 Million. Explore VYTRUS BIOTECH EO -01 debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of VYTRUS BIOTECH EO -01 (2021–2025)
Cash flow reinvestment rate of VYTRUS BIOTECH EO -01 from 2021 to 2025. Historical reinvestment intensity for VYTRUS BIOTECH EO -01 across 5 annual periods. Explore VYTRUS BIOTECH EO -01 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
VYTRUS BIOTECH EO -01 Cash Flow Reinvestment Rate by Year (2021–2025)
VYTRUS BIOTECH EO -01 cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for VYTRUS BIOTECH EO -01. For the full cash flow conversion analysis, see cash flow conversion of VYTRUS BIOTECH EO -01.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | €2.76 Million | €3.90 Million | €2.68 Million | ▲ +8.1% |
| 2024 | 0.65x | €1.21 Million | €1.84 Million | €1.20 Million | ▼ -49.9% |
| 2023 | 1.31x | €1.18 Million | €904.39K | €1.17 Million | ▲ +1.0% |
| 2022 | 1.29x | €1.33 Million | €1.03 Million | €1.29 Million | ▲ +91.3% |
| 2021 | 0.68x | €302.77K | €447.92K | €271.82K | — |